Research graph
References from Multi-modal ensemble learning prediction of anti-TNF treatment response in pediatric patients with Crohn’s disease using clinical, radiomic, and deep learning MR enterography features. Local targets link to admitted publications; unresolved targets remain external evidence.
Geographic distributions of microscopic colitis and inflammatory bowel disease in the United States
10.1002/ibd.22932 · 2012 · External reference
The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States
10.1016/j.cgh.2007.07.012 · 2007 · External reference
Global hospitalization trends for Crohn’s disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses
10.1016/j.cgh.2022.06.030 · 2023 · External reference
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
10.1016/s0140-6736(17)32448-0 · 2017 · External reference
The natural history of adult Crohn’s disease in population-based cohorts
10.1038/ajg.2009.579 · 2010 · External reference
Anti-TNF Therapy in Crohn’s Disease
10.3390/ijms19082244 · 2018 · External reference
Anti-TNF therapy: past, present and future
10.1093/intimm/dxu102 · 2015 · External reference
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: current and novel biomarkers
10.1016/j.ebiom.2021.103329 · 2021 · External reference
Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
10.1038/s41598-021-90660-2 · 2021 · External reference
Loss of response to anti-TNFs: definition, epidemiology, and management
10.1038/ctg.2015.63 · 2016 · External reference
First-line therapy in adult Crohn’s disease: who should receive anti-TNF agents?
10.1038/nrgastro.2013.31 · 2013 · External reference
Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease
10.1007/s00535-017-1324-3 · 2017 · External reference
Early biological therapy within 12 months of diagnosis leads to higher transmural healing rates in Crohn’s disease
10.1016/j.cgh.2024.07.034 · 2025 · External reference
Association of baseline luminal narrowing with ileal microbial shifts and gene expression programs and subsequent transmural healing in pediatric Crohn disease
10.1093/ibd/izaa339 · 2021 · External reference
Magnetic resonance enterography and intestinal ultrasound for the assessment and monitoring of Crohn’s disease
10.1093/ecco-jcc/jjae042 · 2024 · External reference
The role of MR enterography in assessing Crohn’s disease activity and treatment response
10.1155/2016/8168695 · 2016 · External reference
Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
10.1038/srep10223 · 2015 · External reference
Diffusion-weighted magnetic resonance enterography for prediction of response to tumor necrosis factor inhibitors in stricturing Crohn’s disease
10.1007/s00261-018-1626-9 · 2018 · External reference
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
10.1007/s00330-023-09542-y · 2023 · External reference
Deep learning and radiomic feature-based blending ensemble classifier for malignancy risk prediction in cystic renal lesions
10.1186/s13244-022-01349-7 · 2023 · External reference
Deep learning and radiomics in precision medicine
10.1080/23808993.2019.1585805 · 2019 · External reference
Pathophysiology of inflammatory bowel diseases. Reply
10.1056/nejmc2101562 · 2021 · External reference
Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD
10.1016/s0016-5107(04)01878-4 · 2004 · External reference
Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease
10.1148/radiol.2018171737 · 2018 · External reference
Development and validation of a simplified magnetic resonance index of activity for Crohn’s disease
10.1053/j.gastro.2019.03.051 · 2019 · External reference
Machine learning diagnosis of small-bowel Crohn disease using T2-weighted MRI radiomic and clinical data
10.2214/ajr.23.29812 · 2024 · External reference
Computational radiomics system to decode the radiographic phenotype
10.1158/0008-5472.can-17-0339 · 2017 · External reference
Unresolved reference
2016 · External reference
Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification
10.1002/ibd.21493 · 2011 · External reference
Unresolved reference
2025 · External reference
Development and testing of a new simplified endoscopic mucosal assessment for Crohn’s disease: the SEMA-CD
10.1093/ibd/izaa307 · 2021 · External reference
Automating endoscopic scoring through artificial intelligence
10.1016/j.gastha.2025.100674 · 2025 · External reference
Permutation importance: a corrected feature importance measure
10.1093/bioinformatics/btq134 · 2010 · External reference
Nomogram to predict primary non-response to infliximab in patients with Crohn’s disease: a multicenter study
10.1093/gastro/goaa069 · 2021 · External reference
Predicting mucosal healing in Crohn’s disease: development of a deep-learning model based on intestinal ultrasound images
10.1186/s13244-025-02014-5 · 2025 · External reference
Development and validation of a machine learning-based predictive model for clinical remission in Crohn’s disease patients receiving Adalimumab therapy
10.1371/journal.pone.0331447 · 2025 · External reference
Deep-learning, radiomics and clinic based fusion models for predicting response to infliximab in Crohn’s disease patients: a multicentre, retrospective study
10.2147/jir.s484485 · 2024 · External reference
Computed tomography enterography-based deep learning radiomics to predict stratified healing in patients with Crohn’s disease: a multicenter study
10.1186/s13244-024-01854-x · 2024 · External reference
CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease
10.1186/s13244-024-01637-4 · 2024 · External reference
MR enterography of Crohn disease: part 2, imaging and pathologic findings
10.2214/ajr.11.6740 · 2011 · External reference
Facing terminal ileitis: going beyond Crohn’s disease
10.14740/gr698w · 2016 · External reference
